merchants, research organisations and commercial breeders
until we found the right supplier. We are very excited to now
have the seeds in New Zealand for our scientists and plant
breeders to start working with.”
Dr Vidiella has a background in horticultural engineering and
is working with a team of three Hikurangi scientists and four
experienced cannabis breeders in Ruatoria. The Hikurangi
research group is breeding for optimal plant characteristics in
terms of bioactives, yield and resilience.
“We are working on a comprehensive research program and
developing strong alliances with local and international
research institutions, to align our breeding program and
clinical research with the most recent scientific knowledge
on the potential use of medicinal cannabis to treat different
conditions” says Irene Lopez-Ubiria, Chief Research Officer
for Hikurangi.
She goes on “Having recently met with world experts at
the United in Compassion Australian Medicinal Cannabis
Symposium, we are confident in the role Hikurangi can play
in the global medicinal cannabis sector with affordable, top
quality products backed with rigorous science.”
The company is currently negotiating supply agreements
with buyers in Europe, Asia and North America and has plans
to supply New Zealand pharmacies and export a range of
medicinal cannabis products once commercial licenses are
issued in early 2020. q
Anna Fisher
Chief Communications Officer
Hikurangi Cannabis Company
[email protected]
26